<p>Russia has recruited sufficient participants for its large-scale Covid-19 vaccine trial, known as a Phase III trial, the head of Russia's sovereign wealth fund, which is backing the vaccine, said on Monday.</p>.<p>"In just two weeks, 55,000 volunteers have already been recruited in Moscow," Kirill Dmitriev, head of the Russian Direct Investment Fund Said.</p>.<p>Russia began recruiting for what was billed as a 40,000-strong Phase III trial on Aug. 26. Initial results are expected in October or November this year, officials have said.</p>
<p>Russia has recruited sufficient participants for its large-scale Covid-19 vaccine trial, known as a Phase III trial, the head of Russia's sovereign wealth fund, which is backing the vaccine, said on Monday.</p>.<p>"In just two weeks, 55,000 volunteers have already been recruited in Moscow," Kirill Dmitriev, head of the Russian Direct Investment Fund Said.</p>.<p>Russia began recruiting for what was billed as a 40,000-strong Phase III trial on Aug. 26. Initial results are expected in October or November this year, officials have said.</p>